Dose-Response Relationship, Drug
Showing 1 - 25 of >10,000
Dose Response Relationship, Drug Trial in Winston-Salem (F-18 FDG PET)
Terminated
- Dose Response Relationship, Drug
- F-18 FDG PET
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Mar 9, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,
Active, not recruiting
- Infections and Infestations
- Pulmonary Tuberculosis
- Delpazolid
- Bedaquiline, Delamanid, Moxifloxacin
-
Tembisa, Gauteng, South Africa
- +4 more
Sep 13, 2022
Glucose Tolerance Impaired Trial (20% fat meal, 40% fat meal, 60% fat meal)
Not yet recruiting
- Glucose Tolerance Impaired
- 20% fat meal
- +3 more
- (no location specified)
Jun 14, 2023
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Oct 5, 2023
TSI and Its Relationship With Graves' Disease Relapse
Completed
- Graves Disease
- +2 more
- TSI
-
Ho Chi Minh City, VietnamHoa Hao Clinic
Feb 2, 2023
Mild Cognitive Impairment Trial in Tucson (Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (Low Intensity))
Not yet recruiting
- Mild Cognitive Impairment
- Transcranial Magnetic Stimulation
- Transcranial Magnetic Stimulation (Low Intensity)
-
Tucson, ArizonaBioscience Research Laboratory
Aug 22, 2022
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC)
Recruiting
- Treatment Resistant Depression
- Active TBS-DLPFC
- Sham TBS-DLPFC
-
Stanford, CaliforniaDepartment of Psychiatry and Behavioral Sciences, Stanford Schoo
May 5, 2022
Fertilization Trial (corifollitropin alfa, Follitropin beta injection)
Completed
- Fertilization
- corifollitropin alfa
- Follitropin beta injection
- (no location specified)
Feb 1, 2022
Articular Cartilage Degeneration Trial in Basel (walking stress test)
Recruiting
- Articular Cartilage Degeneration
- walking stress test
-
Basel, SwitzerlandDepartment of Orthopaedics and Traumatology, University Hospital
Mar 2, 2022
Healthy Trial in Baltimore (Blinded drug dose conditions)
Recruiting
- Healthy
- Blinded drug dose conditions
-
Baltimore, MarylandBehavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
Nov 8, 2022
Healthy Volunteers Trial in Paris (ILT101, Placebo)
Completed
- Healthy Volunteers
- ILT101
- Placebo
-
Paris, FranceClinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Teheran (Eptacog alfa, activated)
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- Eptacog alfa, activated
-
Teheran, Iran, Islamic Republic ofComprehensive Hemophilia Care Center
Feb 14, 2022
Major Depression in Remission Trial in Ghent (Cognitive control training)
Recruiting
- Major Depression in Remission
- Cognitive control training
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Mar 10, 2022
Psychotic Disorders, Anxiety, Complementary Therapies Trial in Tainan (multisensory stimulation therapy)
Completed
- Psychotic Disorders
- +3 more
- multisensory stimulation therapy
-
Tainan, TaiwanMei-Feng, Lin
Aug 12, 2021
Onchocerciasis Trial in Hohoe (emodepside, matching of emodepside, ivermectin)
Recruiting
- Onchocerciasis
- emodepside
- +3 more
-
Hohoe, Volta Region, GhanaUniversity of Health and Allied Services School of Public Health
Dec 17, 2021
Mitochondrial Function, Glucose Intolerance Trial in Stockholm (Exercise)
Unknown status
- Mitochondrial Function
- Glucose Intolerance
- Exercise
-
Stockholm, SwedenThe Swedish School of Sport and Health Sciences (GIH)
Feb 10, 2021
Influenza, Human Trial in Leiden (POLB 001, Placebo)
Completed
- Influenza, Human
- POLB 001
- Placebo
-
Leiden, NetherlandsCentre for Human Drug Research
Mar 13, 2023
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),
Active, not recruiting
- Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
- Bapotulimab (BAY1905254)
- Bapotulimab (BAY1905254) + Pembrolizumab
-
Tucson, Arizona
- +7 more
Jan 12, 2023
Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)
Completed
- Opioid Dependence
- Acute Opioid Withdrawal Syndrome
- Lofexidine HCl
- +2 more
-
Clovis, California
- +17 more
Mar 11, 2022
Pediatric Adenotonsillectomy, Post Operative Analgesia Trial in Houston (Dexmedetomidine 0.75 mcg/kg, Morphine 50 mcg/kg,
Completed
- Pediatric Adenotonsillectomy
- Post Operative Analgesia
- Dexmedetomidine 0.75 mcg/kg
- +3 more
-
Houston, TexasTexas Children's Hospital, Baylor College of Medicine
Jul 23, 2021
Evaluation of QTc Interval Trial (16 mg buprenorphine with 4 mg naloxone sublingual film)
Withdrawn
- Evaluation of QTc Interval
- 16 mg buprenorphine with 4 mg naloxone sublingual film
- (no location specified)
Oct 7, 2020
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Aug 15, 2023
Propofol Overdose, EEG Trial in Santiago (Propofol, Electroencephalogram recording)
Completed
- Propofol Overdose
- EEG
- Propofol
- Electroencephalogram recording
-
Santiago, RM, Chile
- +1 more
Apr 26, 2021
Critically Ill, Septic Shock Trial in Australia (Fludrocortisone Acetate, Standard Therapy)
Recruiting
- Critically Ill
- Septic Shock
- Fludrocortisone Acetate
- Standard Therapy
-
Sydney, New South Wales, Australia
- +8 more
Mar 29, 2021